Caring Brands, INC. (CABR) — SEC Filings

Overview

Caring Brands, INC. (CABR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Mar 31, 2026: Caring Brands, Inc. (CABR) reported nominal revenues and a net loss of $6,278,191 for the fiscal year ended December 31, 2025, a significant increase from the $1,517,431 net loss in 2024. The company, a wellness consumer products firm, focuses on OTC and cosmetic products, including hair loss, eczem

Sentiment Summary

Across 10 filings, the sentiment breakdown is: 2 bearish, 4 neutral, 4 mixed. The dominant filing sentiment for Caring Brands, INC. is neutral.

Filing Type Overview

Caring Brands, INC. (CABR) has filed 1 10-K, 2 8-K, 1 10-Q, 4 S-1/A, 2 S-1 with the SEC between Mar 2025 to Mar 2026.

Filings by Year

2026 · 2025

Recent Filings (10)

• Caring Brands' Losses Mount Amidst Strategic Relaunch Plans — 10-K · Mar 31, 2026 Risk: high
  Caring Brands, Inc. (CABR) reported nominal revenues and a net loss of $6,278,191 for the fiscal year ended December 31, 2025, a significant increase from the $
• 8-K Filing — 8-K · Mar 31, 2026
• 8-K Filing — 8-K · Nov 17, 2025
• Caring Brands' Cash Dries Up Amidst Mounting Losses — 10-Q · Nov 14, 2025 Risk: high
  Caring Brands, Inc. (CABR) reported a significant net loss of $2,218,121 for the nine months ended September 30, 2025, a substantial increase from the $654,640
• Caring Brands Eyes NASDAQ Listing, $4M Public Offering for Wellness Products — S-1/A · Oct 10, 2025 Risk: high
  Caring Brands, Inc. (CABR) is conducting a public offering of 1,000,000 shares of common stock at an assumed price of $4.00 per share, aiming to raise $4,000,00
• Caring Brands Eyes Nasdaq Listing, $4M Public Offering for Wellness Products — S-1/A · Sep 19, 2025 Risk: high
  Caring Brands, Inc. (CABR) is a wellness consumer products company offering OTC and cosmetic products, with a primary focus on Photocil, a narrow-band UV filter
• Caring Brands Eyes Nasdaq Listing, $4M Public Offering for Wellness Products — S-1/A · Sep 8, 2025 Risk: high
  Caring Brands, Inc. (CABR) is a wellness consumer products company preparing for a public offering of 1,000,000 shares of common stock at an assumed price of $4
• Caring Brands Eyes Nasdaq Uplisting, $4M Public Offering for Wellness Products — S-1 · Aug 21, 2025 Risk: high
  Caring Brands, Inc. (CABR) is undertaking a public offering of 1,000,000 shares of common stock at an assumed price of $4.00 per share, aiming to raise $4,000,0
• Caring Brands, Inc. Amends SEC Registration — S-1/A · Apr 7, 2025 Risk: medium
  Caring Brands, Inc. filed an S-1/A amendment on April 7, 2025, for its registration statement. The company, incorporated in Nevada with its principal executive
• S-1 Filing — S-1 · Mar 20, 2025

Risk Profile

Risk Assessment: Of CABR's 7 recent filings, 6 were flagged as high-risk, 1 as medium-risk, and 0 as low-risk. The overall risk profile suggests elevated risk that warrants close monitoring.

Financial Highlights

Key financial metrics from Caring Brands, INC.'s most recent 10-K filing (Mar 31, 2026):

• Net Income: -$6,278,191

Key Executives

• Glynn Wilson
• Jordan Fried
• Gregory Sichenzia, Esq.
• Arthur S. Marcus, Esq.
• Joseph M. Lucosky, Esq.

Industry Context

Caring Brands, Inc. operates in the wellness consumer products sector, focusing on dermatological solutions for conditions like hair loss, eczema, psoriasis, and vitiligo. The company's strategy involves leveraging phototherapy treatments, a market projected to grow significantly from $1.9 billion in 2023 to $3.23 billion by 2033. Competition exists within the broader psoriasis and vitiligo treatment markets, with the psoriasis market valued at $34 billion and the vitiligo market at $538.90 million in recent periods.

Top Tags

Wellness Products (5) · Public Offering (4) · Photocil (3) · Net Loss (2) · S-1/A Filing (2) · Biotechnology (2) · Emerging Growth Company (2) · Nasdaq Listing (2) · OTC (1) · Cosmetics (1)

Key Numbers

• Net Loss: $6,278,191 — for the year ended December 31, 2025, a significant increase from 2024
• Aggregate Market Value: $3,955,388 — of common stock held by non-affiliates as of June 30, 2025
• Shares Outstanding: 12,341,506 — as of March 30, 2026
• Global Phototherapy Market: $1.9 billion — in 2023, projected to grow
• CAGR: 5.2% — for global phototherapy market from 2023-2033
• Global Psoriasis Treatment Market: $34 billion — in 12 months ending June 2023
• Global Vitiligo Treatment Market: $538.90 million — valued in 2024
• Cash and Cash Equivalents: $16K — Decreased by 96.5% from $468,998 at December 31, 2024, to $16,123 at September 30, 2025.
• Net Sales: $3.8K — Reported for the nine months ended September 30, 2025, indicating minimal revenue generation.
• Selling, General and Administrative Expenses: $2.2M — Major contributor to the net loss for the nine months ended September 30, 2025.
• Decrease in Cash: 96.5% — Percentage drop in cash and cash equivalents from December 31, 2024, to September 30, 2025.
• Common Shares Outstanding: 13,736,925 — As of November 14, 2025, indicating potential dilution from prior periods.
• Intellectual Property, net: $2.6M — Related party asset as of September 30, 2025, down from $2.85M at December 31, 2024.
• Total Current Liabilities: $570K — Increased from $186,105 at December 31, 2024, to $570,210 at September 30, 2025.
• Assumed Public Offering Price per Share: $4.00 — Basis for calculating offering proceeds

Related Companies

CBRA

Frequently Asked Questions